Bioavailability of antihypertensive lactoferricin B-derived peptides: Transepithelial transport and resistance to intestinal and plasma peptidases

International Dairy Journal

Volumn 32, Issue 2, 2013, Pages 169-174

  Fernández Musoles, Ricardo ^a   Salom, Juan B ^b,c   Castelló Ruiz, María ^b   Contreras, María del Mar ^d   Recio, Isidra ^d   Manzanares, Paloma ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; MONOLAYERS;

ANGIOTENSIN I-CONVERTING ENZYME; APPARENT PERMEABILITIES; CELL MONOLAYERS; HUMAN PLASMAS; INTESTINAL CELLS; INTESTINAL MUCOSA; SELECTIVE INHIBITORS; TRANSEPITHELIAL TRANSPORT;

PEPTIDES;

EID: 84879497195     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2013.05.009     Document Type: Article

References (39)

1. Amidon G.L., Lennernas H., Shan V.P., Crison J.R. Atheoretical basis for a biopharmaceutic drug classification - the correlation of invitro drug product dissolution and invivo bioavailability. Pharmaceutical Research 1995, 12:413-420.
2. Campbell D.J. The renin-angiotensin and the kallikrein-kinin systems. International Journal of Biochemistry and Cell Biology 2003, 35:784-791.
3. Cardillo G., Gentilucci L., Tolomelli A., Calienni M., Qasem A.R., Spampinato S. Stability against enzymatic hydrolysis of endomorphin-1 analogues containing beta-proline. Organic and Biomolecular Chemistry 2003, 1:1498-1502.
4. Chua H.-L., Jois S., Sim M.-K., Go M.-L. Transport of angiotensin peptides across the Caco-2 monolayer. Peptides 2004, 25:1327-1338.
5. Contreras M.M., Sancho A.I., Recio I., Mills C. Absorption of casein antihypertensive peptides through an invitro model of intestinal epithelium. Food Digestion 2012, 3:16-24.
6. Fei Y.-J., Kanai Y., Nussberger S., Ganapathy V., Leibach F., Romero M.F., et al. Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 1994, 368:563-566.
7. Foltz M., Cerstiaens A., van Meensel A., Mols R., van der Pijl P.C., Duchateau G.S.M.J.E., et al. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models. Peptides 2008, 29:1312-1320.
8. Foltz M., Meynen E.E., Bianco V., van Platerink C., Koning T.M.M.G., Kloek J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. Journal of Nutrition 2007, 137:953-958.
9. Gao J., Sudoh M., Aubé J., Borchardt R.T. Transport characteristics of peptides and peptidomimetics: I. N-methylated peptides as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa. Journal of Peptide Research 2001, 57:316-329.
10. Gifford J.L., Hunter H.N., Vogel H.J. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cellular and Molecular Life Sciences 2005, 62:2588-2598.
11. Hansen S.-H., Olsson A., Casanova J.-E. Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells. Journal of Biological Chemistry 1995, 270:28425-28432.
12. Hubatsch I., Ragnarsson E.G.E., Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nature Protocols 2007, 2:2111-2119.
13. Iwan M., Jarmolowska B., Bielikowicz K., Kostyra E., Kostyra H., Kaczmarski M. Transport of μ-opioid receptor agonists and antagonist peptides across Caco-2 monolayer. Peptides 2008, 29:1042-1047.
14. Kim D.-C., Burton P.S., Borchardt R.T. Acorrelation between the permeability characteristics of a series of peptides using an invitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa. Pharmaceutical Research 1993, 10:1710-1714.
15. Korhonen H., Pihlanto A. Bioactive peptides: production and functionality. International Dairy Journal 2006, 16:945-960.
16. Lee V.H.L., Yamamoto A. Penetration and enzymatic barrier to peptide and protein absorption. Advanced Drug Delivery Reviews 1990, 4:171-207.
17. Lei L., Sun H., Liu D., Liu L., Li S. Transport of Val-Leu-Pro-Val-Pro in human intestinal epithelial (Caco-2) cell monolayers. Journal of Agricultural and Food Chemistry 2008, 56:3582-3586.
18. Madara J.L., Barenberg D., Carlson S. Effects of cytochalasin D on occluding junctions of intestinal absorptive cells: further evidence that cytoskeleton may influence paracellular permeability and junctional charge selectivity. Journal of Cell Biology 1986, 102:2125-2136.
19. Miguel M., Dávalos A., Manso M.A., de la Peña G., Lasunción M.A., López-Fandiño R. Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-Ile. Molecular Nutrition and Food Research 2008, 52:1507-1513.
20. Mizuno S., Nishimura S., Matsuura K., Gotou T., Yamamoto N. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. Journal of Dairy Science 2004, 87:3183-3188.
21. Pauletti G.M., Gangwar S., Knipp G.T., Nerurkar M.M., Okumu F.W., Tamura K., et al. Structural requirements for intestinal absorption of peptide drugs. Journal of Controlled Release 1996, 41:3-17.
22. Pauletti G.M., Okumu F.W., Borchardt R.T. Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharmaceutical Research 1997, 14:164-169.
23. van der Pijl P.C., Kies A.K., Ten Have G.A., Duchateau G.S., Deutz N.E. Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 2008, 29:2196-2202.
24. Quirós A., Dávalos A., Lasunción M.A., Ramos M., Recio I. Bioavailability of the antihypertensive peptide LHLPLP: transepithelial flux of HLPLP. International Dairy Journal 2008, 18:279-286.
25. Ruiz-Giménez P., Ibáñez A., Salom J.B., Marcos J.F., López-Díez J.J., Vallés S., et al. Antihypertensive properties of lactoferricin B-derived peptides. Journal of Agricultural and Food Chemistry 2010, 58:6721-6727.
26. Ruiz-Giménez P., Salom J.B., Marcos J.F., Vallés S., Martínez-Maqueda D., Recio I., et al. Antihypertensive effect of a bovine lactoferrin pepsin hydrolysate: identification of novel active peptides. Food Chemistry 2012, 131:266-273.
27. Salamat-Miller N., Johnston T.P. Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium. International Journal of Pharmaceutics 2005, 294:201-206.
28. Satake M., Enjoh M., Nakamura Y., Takano T., Kawamura Y., Arai S., et al. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Bioscience Biotechnology and Biochemistry 2002, 66:378-384.
29. Shimizu M. Modulation of intestinal functions by food substances. Nahrung-Food 1999, 43:154-158.
30. Shimizu M., Tsunogai M., Arai S. Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 1997, 18:681-687.
31. Sienkiewicz-Szlapka E., Jarmolowska B., Krawczuk S., Kostyra E., Kostyra H., Bielikowicz K. Transport of bovine milk-derived opioid peptides across a Caco-2 monolayer. International Dairy Journal 2009, 19:252-257.
32. Sun H., Liu D., Li S., Qin Z. Transepithelial transport characteristics of the antihypertensive peptide, Lys-Val-Leu-Pro-Val-Pro, in human intestinal Caco-2 cell monolayers. Bioscience Biotechnology and Biochemistry 2009, 73:293-298.
33. Vermeirssen V., Deplancke B., Tappenden K.A., van Camp J., Gaskins H.R., Verstraete W. Intestinal transport of the lactokinin Ala-Leu-Pro-Met-his-Ile-Arg through a Caco-2 Bbe monolayer. Journal of Peptide Science 2002, 8:95-100.
34. Vermeirssen V., van Camp J., Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition 2004, 92:357-366.
35. Wakabayashi H., Yamauchi K., Takase M. Lactoferrin research, technology and applications. International Dairy Journal 2006, 16:1241-1251.
36. Walsh D.J., Bernard H., Murray B.A., MacDonald J., Pentzien A.K., Wright G.A., et al. Invitro generation and stability of lactokinin beta-globulin fragment (142-148). Journal of Dairy Science 2004, 87:3845-3857.
37. Werner U., Kissel T., Stüber W. Effects of peptide structure on transport properties of seven thyrotropin releasing hormone (TRH) analogues in a human intestinal cell line (Caco-2). Pharmaceutical Research 1997, 14:246-250.
38. Yamada Y., Matoba N., Usiu H., Onishi K., Yoshikawa M. Design of a highly potent anti-hypertensive peptide based on ovokinin (2-7). Bioscience Biotechnology and Biochemistry 2002, 66:1213-1217.
39. Yen W.C., Lee V.H.I. Penetration enhancement effect of Pz-peptide, a paracellularly transported peptide, in rabbit intestinal segments and Caco-2 cell monolayers. Journal of Controlled Release 1995, 36:25-37.